维普中文期刊产品整合服务
360篇 您的检索式:作者名="Piacentini"
    题名 作者 年代 出处 被引量
1Resveratrol corrects aberrant splicing of RYR1 pre-mRNA and Ca2+ signal in myotonic dystrophy type 1 myotubes显示文摘Myotonic dystrophy type 1(DM1) is a spliceopathy related to the mis-splicing of several genes caused by sequestration of nuclear transcriptional RNA-binding factors from non-coding CUG repeats of DMPK pre-mRNAs. Dysregulation of ryanodine receptor 1(RYR1), sarcoplasmatic/endoplasmatic Ca^2+-ATPase(SERCA) and α1 S subunit of voltage-gated Ca^2+ channels(Cav1.1) is related to Ca^2+ homeostasis and excitation-contraction coupling impairment. Though no pharmacological treatment for DM1 exists, aberrant splicing correction represents one major therapeutic target for this disease. Resveratrol(RES, 3,5,4′-trihydroxy-trans-stilbene) is a promising pharmacological tools for DM1 treatment for its ability to directly bind the DNA and RNA influencing gene expression and alternative splicing. Herein, we analyzed the therapeutic effects of RES in DM1 myotubes in a pilot study including cultured myotubes from two DM1 patients and two healthy controls. Our results indicated that RES treatment corrected the aberrant splicing of RYR1, and this event appeared associated with restoring of depolarization-induced Ca^2+ release from RYR1 dependent on the electro-mechanical coupling between RYR1 and Cav1.1. Interestingly, immunoblotting studies showed that RES treatment was associated with a reduction in the levels of CUGBP Elav-like family member 1, while RYR1, Cav1.1 and SERCA1 protein levels were unchanged. Finally, RES treatment did not induce any major changes either in the amount of ribonuclear foci or sequestration of muscleblind-like splicing regulator 1. Overall, the results of this pilot study would support RES as an attractive compound for future clinical trials in DM1. Ethical approval was obtained from the Ethical Committee of IRCCS Fondazione Policlinico Universitario A. Gemelli, Rome, Italy(rs9879/14) on May 20, 2014.Massimo Santoro Roberto Piacentini Alessia Perna Eugenia Pisano Anna Severino Anna Modoni Claudio Grassi Gabriella Silvestri 2020Neural Regeneration Research2020,15,9:3
2Current evidence and future research needs for FeNO measurement in respiratory diseases显示文摘Leif Bjermer Kjell Alving Zuzana Diamant Helgo Magnussen Ian Pavord Giorgio Piacentini David Price Nicolas Roche Joaquin Sastre Mike Thomas Omar Usmani 2014Respiratory Medicine2014,,:2
3Low-dose interleukin-2 administered pre-operatively topatients with gastric cancer activates peripheral and perit-umoral lymphocytes but does not affect prognosis显示文摘Giovanni Carlo Cesana Fabrizio Romano Gaia Piacentini 2007Annals Surgical Oncology2007,14,4:1
4On the influence of tool path in friction stir spot welding of aluminum alloys显示文摘Buffa G Fratini L Piacentini M 2008Journal of Materials Processing Technology2008,208,13:1
5Investigation on the effects of a mechanical shear-stress modification method during cross-flow membrane emulsification显示文摘Andras Koris Emma Piacentini Gyula Vatai Erika Bekassy-Molnar Enrico Drioli Lidietta Giorno 2011Journal of Membrane Science2011,,1:1
6Reduction of subjective distress in CBT for childhood OCD: nature of change, predictors, and relation to treatment outeom显示文摘Kireanski K Wu M Piacentini J 2014J Anxiety Disord2014,28,2:1
7Endothelin-1 Stimulates Cardiac Fibroblast Proliferation Through Activation of Protein Kinase C显示文摘Lucia Piacentini Mary Gray Norman Y Honbo Jamila Chentoufi Marina Bergman Joel S Karliner 2000Journal of Molecular and Cellular Cardiology2000,,4:1
8Achievements and unmet needs in the management of advanced ovarian cancer显示文摘Guarneri V Piacentini F Barbieri E 2010GynecolOncol2010,117,2:1
9Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones显示文摘Iacopino F Angelucci C Piacentini R 2014PloS One2014,9,10:1
10Platinum doublets as first-line treatment for elderly patients with advanced non- small cell lung cancer 显示文摘Piacentini P Greco F Mercanti A 2013Tumori2013,99,6:1
11Vitamin D Serum Levels and Markers of Asthma Control in Italian Children显示文摘Iolanda Chinellato Michele Piazza Marco Sandri Diego Peroni Giorgio Piacentini Attilio L. Boner 2011The Journal of Pediatrics2011,,3:1
12Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children显示文摘Piacentini GL Bodini A Costella S 1999Eur Respir J1999,13,:1
13Influence of brain catecholamines on the development of fatigue in ex- ercising rats in the heat 显示文摘Hasegawa H Piacentini MF Sarre S 2008J Physiol2008,586,1:1
14Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms 显示文摘Pappagallo M Oaklander AL Quatrano Piacentinial 2000Anesthesiology2000,92,3:1
15GSTO1 E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant 显示文摘Piacentini S Polimanti R Squitti R 2012Neurosci Lett2012,506,:1
16Quantitative PCR analysis of two molluscan metallothionein genes unveils differential expression and regulation 显示文摘Dondero F Piacentini L Banni M 2005Gene2005,345,2:1
17Transglutaminase 2: an enigmatic enzyme with diverse functions显示文摘Fesus L Piacentini M 2002Trends Biochem Sei2002,27,10:1
18An extension of metric temporal planning with application to AC voltage control显示文摘Piacentini C Alimisis V Fox M 2015Artificial Intelligence2015,229,12:1
19Brain microdialysis in exercise research显示文摘Meeusen R Piacentini MF De Meirleir K 2001Sports Med2001,31,14:1
20Conjoined lumbosacral nerve roots: observations on three cases and review of the literature 显示文摘Artico M Carloia S Piacentini M 2006Neurocirugia2006,17,:1
返回顶部 每页显示:
共18页 首页 上一页 第1页 下一页 末页 /18 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费